Reckitt Benckiser Group (RBGLY)
OTHER OTC:RBGLY
Want to see RBGLY full AI Analyst Report?
RBGLY Stock Chart & Stats
$15.72
$0.07(0.58%)
At close: 4:00 PM EST
$15.72
$0.07(0.58%)
Day’s Range― - ―
52-Week Range$12.54 - $17.61
Previous CloseN/A
VolumeN/A
Average Volume (3M)20.41K
Market Cap
$41.08B
Enterprise Value$36.26B
Total Cash (Recent Filing)$1.95B
Total Debt (Recent Filing)$8.42B
Price to Earnings (P/E)12.6
Beta0.13
Next Earnings
Jul 29, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend Yield3.33%
Share Statistics
EPS (TTM)0.49
Shares Outstanding3,204,072,000
10 Day Avg. Volume0
30 Day Avg. Volume20,409
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.08
Price to Sales (P/S)2.83
P/FCF Ratio22.79
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit4.21
Enterprise Value/Ebitda7.72
Forecast
1Y Price Target
$14.60Price Target Upside-7.12% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.9
Revenue Forecast (FY)$17.18B
Bulls Say, Bears Say
Bulls Say
Emerging Markets OutperformanceSustained double‑digit like‑for‑like growth and 210bp margin expansion in Emerging Markets signals durable structural tailwinds: faster urbanization, online penetration and pricing power there underpin a multi‑year growth engine and meaningfully higher operating leverage.
High Margins And ProfitabilityA near‑25% adjusted operating margin and strong gross/net margins reflect enduring category pricing, brand strength and scale in procurement. These structural margin advantages create room for reinvestment and resilience through commodity/FX cycles over the medium term.
Consistent Cash Generation And Shareholder ReturnsConsistent positive free cash flow above £1bn enables material capital returns (dividends, buybacks) while funding capex and innovation. This cash generation track record supports capital allocation flexibility and signals durable operational cash strength.
Bears Say
Elevated Leverage And Near‑term Rise In Net Debt/EBITDAMeaningful leverage (debt in the $8.5–$10.6B range and rising net debt/EBITDA) reduces financial flexibility and raises refinancing and rate sensitivity risk. Higher gearing constrains M&A, increases interest exposure, and limits cushion against earnings volatility.
Top‑line Softness And Uneven Category MomentumSequential revenue declines and uneven share performance across CMUs indicate structural demand and competitive pressures in developed markets. Sustained top‑line weakness forces reliance on cost cuts for EPS, which is less durable than organic growth recovery.
Lower Cash Conversion, Elevated CapEx And Stranded‑cost RiskDeclining FCF conversion, higher capex to localize capacity and stranded costs from the Essential Home divestment create execution and cash‑strain risk. If productivity programs underdeliver, margins and deleveraging timelines could weaken materially.
Reckitt Benckiser Group News
RBGLY FAQ
What was Reckitt Benckiser Group’s price range in the past 12 months?
Reckitt Benckiser Group lowest stock price was $12.54 and its highest was $17.61 in the past 12 months.
What is Reckitt Benckiser Group’s market cap?
Reckitt Benckiser Group’s market cap is $41.08B.
When is Reckitt Benckiser Group’s upcoming earnings report date?
Reckitt Benckiser Group’s upcoming earnings report date is Jul 29, 2026 which is in 86 days.
How were Reckitt Benckiser Group’s earnings last quarter?
Reckitt Benckiser Group released its earnings results on Mar 05, 2026. The company reported $0.491 earnings per share for the quarter, missing the consensus estimate of $0.511 by -$0.02.
Is Reckitt Benckiser Group overvalued?
According to Wall Street analysts Reckitt Benckiser Group’s price is currently Overvalued.
Does Reckitt Benckiser Group pay dividends?
Reckitt Benckiser Group pays a Quarterly dividend of $0.227 which represents an annual dividend yield of 3.33%. See more information on Reckitt Benckiser Group dividends here
What is Reckitt Benckiser Group’s EPS estimate?
Reckitt Benckiser Group’s EPS estimate is 0.42.
How many shares outstanding does Reckitt Benckiser Group have?
Reckitt Benckiser Group has 3,204,072,000 shares outstanding.
What happened to Reckitt Benckiser Group’s price movement after its last earnings report?
Reckitt Benckiser Group reported an EPS of $0.491 in its last earnings report, missing expectations of $0.511. Following the earnings report the stock price went down -6.097%.
Which hedge fund is a major shareholder of Reckitt Benckiser Group?
Currently, no hedge funds are holding shares in RBGLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Benckiser Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.60 (-7.12% Downside)
$14.60 (-7.12% Downside)
Blogger Sentiment
Neutral
RBGLY Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.6M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.22%
12-Months-Change
Fundamentals
Return on Equity
38.45%
Trailing 12-Months
Asset Growth
6.42%
Trailing 12-Months
Company Description
Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
RBGLY Company Deck
RBGLY Earnings Call
Q4 2026
0:00 / 0:00
RBGLY Stock 12 Month Forecast
Average Price Target
$14.60
▼(-7.12% Downside)
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.94% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---